# Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment

> **NCT03427268** · PHASE2 · COMPLETED · sponsor: **PharmaMar** · enrollment: 32 (actual)

## Conditions studied

- Advanced Colorectal Cancer

## Interventions

- **DRUG:** PM060184

## Key facts

- **NCT ID:** NCT03427268
- **Lead sponsor:** PharmaMar
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-16
- **Primary completion:** 2019-02-11
- **Final completion:** 2019-02-11
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03427268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03427268, "Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03427268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*